Fecal microbiota

Fecal microbiota, sold under the brand name, Rebyota is used for the prevention of recurrence of Clostridioides difficile infection.

Uses your system voice; voice and rate in settings.

Snapshot

≈ 1 min read

Names in other languages

No names in other languages are held for this entry yet.

Article bodies are English and are not machine-translated. A name in another language is not a translation of the article.

Fecal microbiota, sold under the brand name, Rebyota is used for the prevention of recurrence of Clostridioides difficile infection. The most commonly reported adverse reactions include abdominal pain, diarrhea, abdominal distention, flatulence, and nausea. Fecal microbiota is prepared from stool donated by qualified individuals.

The donors and the donated stool are tested for a panel of transmissible pathogens. Fecal microbiota is the first fecal microbiota product approved by the US Food and Drug Administration (FDA). Fecal microbiota was approved for medical use in the United States in November 2022.

Text derived from https://en.wikipedia.org/w/index.php?oldid=1292959164 under CC BY-SA 4.0; modifications have been made.

Sources cited in this revision

6 named source(s) extracted from the cited revision. A source with no author is shown by its publication; nothing is invented.